Jin Medical International (ZJYL) Cash & Current Investments (2022 - 2025)

Jin Medical International has disclosed Cash & Current Investments across 4 years of filings, most recently posting $29.6 million for Q3 2025.

• Cash & Current Investments for Q3 2025 came in at $29.6 million, up 59.12% year-over-year; the trailing twelve-month figure through Sep 2025 was $29.6 million (changed N/A YoY), and the FY2025 annual result was $29.6 million, up 59.12% from the prior year.
• Cash & Current Investments came in at $29.6 million for Q3 2025 at Jin Medical International, up from $28.0 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $29.6 million in Q3 2025 to a low of $2.3 million in Q3 2022.
• The 4-year median for Cash & Current Investments is $18.6 million (2024), against an average of $17.4 million.
• Across the five-year window, Cash & Current Investments jumped 329.18% in 2023 and grew 16.3% in 2025, its largest moves.
• Jin Medical International's Cash & Current Investments stood at $2.3 million in 2022, then surged by 329.18% to $9.8 million in 2023, then jumped by 90.62% to $18.6 million in 2024, then soared by 59.12% to $29.6 million in 2025.
• The last three Cash & Current Investments figures came in at $29.6 million (Q3 2025), $28.0 million (Q1 2025), and $18.6 million (Q3 2024), per Business Quant data.